Podcast #82 · 22 Sept 2026
Advances in Perioperative Colorectal Cancer Management
- Medical Oncology
- Immunotherapy
- Gastrointestinal Oncology (GI Oncology)
- Multidisciplinary Care
- Colorectal Cancer (CRC)
- Surgical Oncology
How much of perioperative colorectal cancer management has changed in just one year, and what does it mean for patient care? On this episode of BackTable Tumor Board, Dr. Jun Gong is joined by Dr. Ibrahim Sahin and Dr. Alexandra Gangi to review the latest practice-changing data in colon and rectal cancer. They discuss observation versus maintenance immunotherapy in MSI-high disease, the CHALLENGE trial's surprising results on exercise and disease-free survival, and the evolving role of ctDNA and local therapies after liver metastasis resection.
Timestamps
Resources
- CHALLENGE Trial: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
- ATOMIC Trial (Alliance A021502): Atezolizumab plus FOLFOX for Stage III Mismatch Repair Deficient Colon Cancer
- Phase 2 LAVA-CRLM Trial: Microwave Ablation versus SBRT for Colorectal Liver Metastases
- COLLISION Trial: Thermal Ablation versus Surgical Resection of Small-Size Colorectal Liver Metastases